Accelrys to Present to Investors at the Thomas Weisel Partners Healthcare Conference.SAN DIEGO -- Accelrys, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ACCL ACCL American Canadian Caribbean Line ACCL Acceleration ACCL American College of Construction Lawyers ACCL Accreditation Council for Clinical Lipidology (Allied Health Certification Program) ACCL Amway China Co Limited ), the leading provider of scientific business intelligence software and services announced today that its CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Mark Emkjer, will present at the Thomas Weisel Partners Thomas Weisel Partners Group, Inc. (NASDAQ: TWPG), often shortened to just TWP or TWeisel, is a U.S. middle-market and growth focused investment banking firm based in San Francisco, California. Healthcare Conference in Boston on September 6, 2007 at 10:20 a.m. ET. The conference will take place at the Four Seasons Hotel September 5th-7th. In attendance will be securities analysts, fund managers, and institutional investors. The company will host a live web cast of the conference presentation at 10:20 a.m. ET on Thursday, September 6, 2007. This web cast can be accessed through the Investor Relations Investor relations The process by which the corporation communicates with its investors. section of Accelrys' web site at www.accelrys.com or by visiting the following web address: http://www.veracast.com/webcasts/twp/healthcare07/38205522.cfm To learn more about Thomas Weisel Partners, please visit www.tweisel.com. About Accelrys, Inc. Accelrys develops and commercializes Scientific Business Intelligence[TM] software for the integration, mining, analysis, modeling and simulation, management and interactive reporting of scientific data. Our solutions are used by biologists, chemists, materials scientists, and information technology professionals for product design as well as drug discovery and development. Our technology and services are designed to meet the needs of today's leading research and development organizations including leading commercial, government and academic organizations. Many of the largest pharmaceutical, biotechnology, chemical, and petroleum companies worldwide use our solutions. Accelrys is headquartered in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation). San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951. . For more information about Accelrys, visit its website at http://www.accelrys.com/. Forward-Looking Statements Statements contained in this press release relating to the Company's or management's intentions, hopes, beliefs, expectations or predictions of the future are forward-looking statements. Such forward looking statements, including but not limited to statements relating to the future success of the consortium, release and demand for products and services resulting therefrom, are subject to a number of risks and uncertainties, including risks that the Consortium will not be successful and that products and services will not be successfully developed therein, risks related to the demand for such products and services, as well as the risks and uncertainties that are contained from time to time in the Company's SEC filings, including but not limited to the Company's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended March 31, 2006, quarterly reports on Form 10-Q Form 10-Q See 10-Q. and current reports on Form 8-K Form 8-K The form required by the SEC when a publicly held company incurs any event that might affect its financial situation or the share value of its stock. Form 8-K See 8-K. . The Company's actual results could differ materially from those projected in such forward-looking statements due to these risks and uncertainties, and the Company disclaims any intention or obligation to revise any forward-looking statements whether as a result of new information, future events or otherwise. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion